Self-monitoring and treatment of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases
Open Access
- 3 July 2020
- journal article
- research article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (3) , 2567
Abstract
In the current epidemic of a new coronavirus infection, COVID-19 treatment of patients with chronic non-communicable diseases (NCDS) and cardiovascular diseases (CVD), in particular, requires close attention of doctors. The main objectives of such patients’ management tactics are to ensure that patients comply with self-isolation measures that prevent infection, motivate patients to follow all medical recommendations. Special attention should be paid to comply with recommended treatment of CVD. In the case of an infectious disease, it is necessary to assess the prescribed therapy for interaction with medications already taken by the patient. However, the tactics for COVID-19 therapy, including in patients with NCDS, may change over time, since there are currently no drugs with proven effectiveness for the treatment of a new coronavirus infection.Keywords
This publication has 8 references indexed in Scilit:
- Considerations for drug interactions on QTc interval in exploratory COVID-19 treatmentHeart Rhythm, 2020
- RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)Mayo Clinic Proceedings, 2020
- Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 PandemicJACC, 2020
- Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemicRussian Journal of Cardiology, 2020
- SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?European Heart Journal, 2020
- RESPONSIBLE SELF-CARE – THE FUNDAMENTAL PRINCIPLES AND PLACE IN THE MODERN RUSSIAN HEALTHCARE SYSTEMRational Pharmacotherapy in Cardiology, 2018
- Medication AdherenceCirculation, 2009